Filter Results:
(3,576)
Show Results For
- All HBS Web
(6,775)
- People (18)
- News (2,151)
- Research (3,576)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
Show Results For
- All HBS Web
(6,775)
- People (18)
- News (2,151)
- Research (3,576)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
Sort by
- March 2023 (Revised March 2024)
- Case
The Purdue Pharma Bankruptcy: Settling the Opioid Crisis
By: Kristin Mugford, Carin-Isabel Knoop and Susan Pinckney
How to get to a fair outcome for claimants in the Purdue Pharma bankruptcy given its significant role in the U.S. opioid crisis. View Details
Keywords: Regulation; Ethics; Fairness; Insolvency and Bankruptcy; Government Legislation; Courts and Trials; Laws and Statutes; Lawsuits and Litigation; Legal Liability; Crime and Corruption; Negotiation Offer; Negotiation Participants; Negotiation Style; Product Design; Product Development; Brands and Branding; Marketing Strategy; Trust; Government and Politics; Law; Negotiation; Operations; Ownership; Marketing; Social Psychology; Health Care and Treatment; Pharmaceutical Industry; United States
Mugford, Kristin, Carin-Isabel Knoop, and Susan Pinckney. "The Purdue Pharma Bankruptcy: Settling the Opioid Crisis." Harvard Business School Case 223-060, March 2023. (Revised March 2024.)
- July 1994 (Revised March 1996)
- Case
Baxter International: OnCall as Soon as Possible?
Baxter Healthcare is heir to the fabled ASAP ordering system, one of the best-known examples of the use of technology to provide strategic marketing advantage. By 1994, the proprietary ASAP system is well established. Baxter is beginning to launch On-Call EDI, which is... View Details
Keywords: Information Technology; Competitive Advantage; Business Strategy; Information Technology Industry; Information Technology Industry
Sviokla, John J., and Chris L Marshall. "Baxter International: OnCall as Soon as Possible?" Harvard Business School Case 195-103, July 1994. (Revised March 1996.)
- April 1993
- Teaching Note
Becton Dickinson Division: Marketing Organization TN
Teaching Note for (9-593-070). View Details
- September 1988 (Revised November 1988)
- Supplement
Watt Group: Consumer Product and Retailing Doctors (B)
By: Ray A. Goldberg
Goldberg, Ray A. "Watt Group: Consumer Product and Retailing Doctors (B)." Harvard Business School Supplement 589-052, September 1988. (Revised November 1988.)
- January 2009
- Case
When Supply is of Public Interest: Roche & Tamiflu
The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
- 07 Feb 2012
- First Look
First Look: February 7
fairness within the industry. Coordinating conflicting programs requires a careful balance between equity and efficiency. In our work, we first develop a fairness metric to measure deviation from first-scheduled, first-served in the... View Details
Keywords: Sean Silverthorne
- October 2020
- Teaching Plan
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
- January 2011 (Revised March 2011)
- Case
Predictive Biosciences
By: Thomas R. Eisenmann, Jeffrey J. Bussgang and David Kiron
A small cancer diagnostics start-up is deciding whether to acquire a laboratory to make and sell its bladder cancer test or build its own manufacturing and sales team. View Details
Keywords: Mergers and Acquisitions; Factories, Labs, and Plants; Business Startups; Entrepreneurship; Health Testing and Trials; Growth and Development Strategy; Product Development; Biotechnology Industry
Eisenmann, Thomas R., Jeffrey J. Bussgang, and David Kiron. "Predictive Biosciences." Harvard Business School Case 811-015, January 2011. (Revised March 2011.)
- November 2020 (Revised January 2021)
- Supplement
Bridge International Academies in 2020: Battling Headwinds to Solve Africa's Education Problems
By: Caroline M. Elkins, Tarun Khanna and Joyce J. Kim
By 2020, Bridge International Academies and its "school in a box" model had achieved great scale. By leveraging digital technology and public-private partnerships, they had reached one million children across Africa and India through hundreds of schools. However, the... View Details
Keywords: Entrepreneurship In Africa; Entrepreneurship In Emerging Markets; Bottom Of The Pyramid; Education In Africa; Scale; Partnerships; Education; Entrepreneurship; Emerging Markets; Health Pandemics; Problems and Challenges; Education Industry; Africa
Elkins, Caroline M., Tarun Khanna, and Joyce J. Kim. "Bridge International Academies in 2020: Battling Headwinds to Solve Africa's Education Problems." Harvard Business School Supplement 521-048, November 2020. (Revised January 2021.)
- 29 Apr 2014
- First Look
First Look: April 29
Harvard Business School Case 413-096 Novartis: Leading a Global Enterprise Novartis, the world's leading health care company, was formed in 1996 out of a merger of two very different, mid-tier... View Details
Keywords: Sean Silverthorne
- 06 Nov 2012
- First Look
First Look: November 6
spillovers. We conduct a field experiment in which agents recruited by a public health organization to sell condoms are randomly allocated to four groups. Agents in the control group are hired as volunteers, whereas agents in the three... View Details
Keywords: Sean Silverthorne
- February 1998 (Revised October 1998)
- Background Note
Note on New Drug Development in the United States
By: Stefan H. Thomke and Ashok Nimgade
An overview of the new drug development process in the United States, using the migraine drug Imitrex as an illustrative example. View Details
Keywords: Product Development; Research and Development; Health; Pharmaceutical Industry; United States
Thomke, Stefan H., and Ashok Nimgade. "Note on New Drug Development in the United States." Harvard Business School Background Note 698-028, February 1998. (Revised October 1998.)
- 2006
- Chapter
BioRisk: interleukin-2 from laboratory to market in the United States and Germany
By: Arthur A. Daemmrich
- 05 Apr 2004
- What Do You Think?
Should We Brace Ourselves for Another Era of M&A Value Destruction?
terms of value created for customers, employees, and shareholders? If the latter, is it the natural result of a system of incentives geared to short-term financial rather than longer-term business benefits? And what does it say about the overall future strength of... View Details
Keywords: by James Heskett
- 13 Nov 2007
- Research & Ideas
Six Steps for Reinvigorating America
to act as "citizen diplomats," spreading greater understanding of our values and helping countries that empower their people and build their economies. Develops an ethos of a community that cares about others and a program of... View Details
Keywords: by Sean Silverthorne
- 12 Apr 2011
- First Look
First Look: April 12
Universal Health Care Is the Best Solution Authors: Regina E. Herzlinger Publication: In Current Controversies: Health Care, edited by Noel Merino. Farmington Hills, MI:... View Details
Keywords: Sean Silverthorne
- November 2024
- Case
Polish Agro: Where Do We Grow From Here?
By: Willy C. Shih, Lena Duchene and Daniela Beyersdorfer
By July 2024, Polish Agro had grown into one of Poland’s fastest-growing agribusinesses, with €230 million in revenue, 82 employees, and operations across Northern Poland. The company supported farmers with essential agricultural inputs like fertilizers and seeds,... View Details
Keywords: Plant-Based Agribusiness; Distribution; Volatility; Customer Focus and Relationships; Customer Value and Value Chain; Climate Change; Environmental Regulation; Profit; Trade; Digital Strategy; Innovation Strategy; Crisis Management; Growth and Development Strategy; Resource Allocation; Advertising; Brands and Branding; E-commerce; Business and Community Relations; Networks; Adaptation; Adoption; Competitive Advantage; Business Model; Health Pandemics; War; Agriculture and Agribusiness Industry; Europe; Poland
- 23 Jan 2018
- First Look
First Look at New Research and Ideas, January 23, 2018
consequence of actual leverage than it is of risk premiums. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53733 2017 India as a Pioneer of Innovation The Private Provision of Missing Public Goods: Evidence from Narayana View Details
Keywords: Sean Silverthorne
- 28 May 2012
- Research & Ideas
A Pragmatic Alternative for Creating a Corporate Social Responsibility Strategy
treating its employees well. The company provides staffers with free education services to complete high school and supplementary medical care to cover gaps in government health plans. These efforts have... View Details
Keywords: by Dina Gerdeman
- 20 Dec 2004
- Research & Ideas
How an Order Views Your Company
the order management cycle? Benson Shapiro: In the late 1970s, when I was teaching the Industrial Marketing course in the MBA program at Harvard, it began to become clear to me that to really manage many businesses, one needed to deal... View Details
Keywords: by Sarah Jane Johnston